Neeraj Kumar Rai

Neeraj Kumar Rai

Director Director DIN 07220710
DIN 07220710 First appointment Jun 2015 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Past companies 2 historical roles
Total affiliations 2 Since Jun 2015
Shareholding value •••• Premium profile

About Neeraj Kumar Rai

Data last updated:

Neeraj Kumar Rai was a Director at Naos Lifesciences Private Limited (2022–2023) and Director at N.R. Remedies Private Limited (2015–2019). The companies operate in Chemicals and Healthcare.

DIN 07220710
Primary Designation Director
Industry Chemicals
First Appointment 29 Jun 2015

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Naos Lifesciences Private Limited U24290DL2022PTC407459
Director25 Nov 20222022₹45.5 Lakh (FY 2025)Active
N.R. Remedies Private Limited U85191UP2015PTC071678
Director29 Jun 20152015Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Naos Lifesciences Private Limited
N.R. Remedies Private Limited
Premium access

Shareholding and investment profile for Neeraj Kumar Rai

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Neeraj Kumar Rai

Neeraj Kumar Rai was first appointed on 29 Jun 2015 as Director at N.R. Remedies Private Limited. The most recent appointment on record is 25 Nov 2022 at Naos Lifesciences Private Limited.

Neeraj Kumar Rai held 2 earlier board appointments: Naos Lifesciences Private Limited (Director, 25 Nov 2022 to 25 Feb 2023); N.R. Remedies Private Limited (Director, 29 Jun 2015 to 12 Jun 2019).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available